Evaluation of the Risk Factors for Cellulitis among Patients with Peripheral Artery Disease

被引:0
|
作者
Wang, Bo-Yuan [1 ,2 ,3 ]
Yang, Shun-Fa [1 ,4 ]
Ting, Ke-Hsin [5 ,6 ]
Wang, Yu-Hsun [4 ]
Chou, Ming-Chih [1 ,7 ]
Yeh, Chao-Bin [1 ,2 ,3 ]
机构
[1] Chung Shan Med Univ, Inst Med, Taichung 402, Taiwan
[2] Chung Shan Med Univ, Sch Med, Taichung 402, Taiwan
[3] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung 402, Taiwan
[4] Chung Shan Med Univ Hosp, Dept Med Res, Taichung 402, Taiwan
[5] Changhua Christian Hosp, Dept Internal Med, Div Cardiol, Yunlin Branch, Changhua 648, Taiwan
[6] Natl Chung Hsing Univ, Coll Med, Dept Postbaccalaureate Med, Taichung 402, Taiwan
[7] Chung Shan Med Univ Hosp, Dept Surg, Taichung 402, Taiwan
来源
MEDICINA-LITHUANIA | 2023年 / 59卷 / 05期
关键词
peripheral occlusion artery disease (PAOD); cellulitis; population-based cohort study; CRITICAL LIMB ISCHEMIA; OCCLUSIVE DISEASE; PREVALENCE; SKIN; INFECTIONS;
D O I
10.3390/medicina59050933
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: The objective of this study is to elucidate peripheral occlusion artery disease (PAOD) as a risk factor for cellulitis. Materials and Methods: This is a retrospective population-based cohort study. The database is the Longitudinal Health Insurance Database, which covers two million beneficiaries from the entire population of the 2010 registry for beneficiaries in Taiwan. The PAOD group is composed of patients who were newly diagnosed with PAOD from 2001 to 2014. The non-PAOD group is composed of patients who were never diagnosed with PAOD from 2001 to 2015. All patients were followed until the onset of cellulitis, death, or until the end of 2015. Results: Finally, 29,830 patients who were newly diagnosed with PAOD were included in the PAOD group, and 29,830 patients who were never diagnosed with PAOD were included in the non-PAOD group. The incidence densities (ID) of cellulitis were 26.05 (95% CI = 25.31-26.80) patients per 1000 person-years in the PAOD group and 49.10 (95% CI = 48.04-50.19) in the non-PAOD group. The PAOD group had an increased risk of cellulitis (adjusted HR = 1.94, 95% CI = 1.87-2.01) compared to the non-PAOD group. Conclusions: Patients with PAOD were associated with a higher risk of subsequent cellulitis compared to patients without PAOD.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Characteristics of prevalence in peripheral arterial disease and correlative risk factors and comorbidities among female natural population in China
    Wang, Y.
    Xu, Y.
    Li, J.
    Wei, Y.
    Zhao, D.
    Hou, L.
    Hasimu, B.
    Yang, J.
    Yuan, H.
    Hu, D.
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2010, 39 (04) : 305 - 311
  • [42] Peripheral artery disease patients are poorly aware of their disease
    Builyte, Inga Urte
    Baltrunas, Tomas
    Butkute, Egle
    Srinanthalogen, Reshaabi
    Skrebunas, Arminas
    Urbonavicius, Sigitas
    Rucinskas, Kestutis
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2019, 53 (06) : 373 - 378
  • [43] Factors associated with positive findings of deep infection on computed tomography among patients with extremity cellulitis
    Burke, Cynthia E.
    Maley, Owen R.
    Mancini, Benjamin
    Sardesai, Sahil
    Montgomery, Austin B.
    King, Tonya S.
    Flemming, Donald J.
    DIAGNOSIS, 2025,
  • [44] Evaluation of Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Type 2 Diabetic Patients with Longer Duration of Diabetes
    Alshammari, Nawaf A.
    Alodhayani, Abdulaziz A.
    Joy, Salini S.
    Isnani, Arthur
    Mujammami, Muhammad
    Alfadda, Assim A.
    Siddiqui, Khalid
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 3007 - 3014
  • [45] Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type 2 diabetes mellitus
    Hsieh, Ming-Chia
    Tien, Kai-Jen
    Perng, Daw-Shyong
    Hsiao, Jeng-Yueh
    Chang, Shun-Jen
    Liang, Hui-Ting
    Chen, Hung-Chun
    Tu, Shih-Te
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2009, 58 (04): : 504 - 509
  • [46] Clinical Outcome and Diverse Risk Factors for Different Therapeutic Target Locations of Peripheral Artery Disease
    Ko, Toshiyuki
    Higashitani, Michiaki
    Uemura, Yukari
    Utsunomiya, Makoto
    Yamaguchi, Tetsuo
    Matsui, Akihiro
    Ozaki, Shunsuke
    Tobita, Kazuki
    Kodama, Takahide
    Morita, Hiroyuki
    Komuro, Issei
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2020, 27 (08) : 769 - 779
  • [47] Cause of Death Among Patients With Peripheral Artery Disease Insights From the EUCLID Trial
    Kochar, Ajar
    Mulder, Hillary
    Rockhold, Frank W.
    Baumgartner, Iris
    Berger, Jeffrey S.
    Blomster, Juuso, I
    Fowkes, F. Gerry R.
    Katona, Brian G.
    Lopes, Renato D.
    Al-Khalidi, Hussein R.
    Mahaffey, Kenneth W.
    Norgren, Lars
    Hiatt, William R.
    Patel, Manesh R.
    Jones, W. Schuyler
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2020, 13 (11): : E006550
  • [48] Trends in patient characteristics and mortality among Medicare patients diagnosed with peripheral artery disease
    Fowler, Xavier
    Mehta, Kunal
    Eid, Mark
    Gladders, Barbara
    Kearing, Stephen
    Moore, Kayla O.
    Creager, Mark A.
    Austin, Andrea M.
    Feinberg, Mark W.
    Bonaca, Marc P.
    Greenland, Philip
    Mcdermott, Mary M.
    Goodney, Philip P.
    VASCULAR MEDICINE, 2024, 29 (06) : 653 - 663
  • [49] Clinical factors associated with peripheral artery disease in patients with documented coronary artery disease: A post hoc analysis of the COMPASS trial
    Gouda, Pishoy
    Ramasundarahettige, Chinthanie
    Anand, Sonia
    Muhlhoffer, Eva
    Berkowitz, Scott
    Fox, Keith Aa
    Eikelboom, John
    Welsh, Robert
    ATHEROSCLEROSIS, 2021, 331 : 38 - 44
  • [50] Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides
    Cengiz, Fatma Pelin
    Emiroglu, Nazan
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2015, 90 (01) : 36 - 40